NanoHive Medical specializes in innovative spinal fusion solutions, particularly through its proprietary Soft Titanium® technology. This technology features bioactive 3D printed titanium interbody devices designed to address the challenges associated with traditional spinal fusion methods. The unique rhombic dodecahedron lattice structure of the implants mimics the properties of cancellous bone, providing an effective modulus comparable to PEEK while significantly reducing implant stiffness. This design not only supports biomechanical loading but also enhances bone formation by stimulating osteoblast activity, leading to improved patient outcomes and reduced reoperation rates.

The implants are engineered to promote rapid bony ingrowth, with a porous structure that allows for optimal cell flow and bone attachment. The NanoHive Soft Titanium® lattice boasts a surface area that is up to 20 times greater than traditional materials, facilitating faster implant stability and integration with host bone. Additionally, the low-density design of these implants allows for superior imaging capabilities, enabling surgeons to easily assess fusion progress through x-ray and CT scans. Overall, NanoHive Medical's advanced technologies aim to enhance the effectiveness and safety of spinal fusion procedures, providing significant benefits to both patients and healthcare providers.

United States

NanoHive Medical (formerly HD LifeSciences) created the proprietary, biomimetic Soft Titanium technology, which clearly distinguishes their products in the $1.9B spinal interbody fusion device market.  The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.

NanoHive Medical

Company Details